Purdue Pharma’s Creditors Overwhelmingly Endorse Bankruptcy Plan

If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help cover costs from the opioid epidemic.

View original article
Contributor: Jan Hoffman